サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1629315

塞栓療法の世界市場：製品別・用途別・最終用途別・処置別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Embolotherapy Market, By Product, By Application, By End Use, By Procedure, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 311 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
塞栓療法の世界市場：製品別・用途別・最終用途別・処置別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2024年12月04日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

塞栓療法の市場規模は2024年に41億1,520万米ドルとなり、2025年から2032年にかけてCAGR 8.60%で拡大

塞栓療法の市場力学

対象患者の拡大による対象処置の増加

塞栓療法機器市場は、対象患者層の拡大による対象処置の増加により、過去10年間で着実に成長してきました。CVDは主要な対象疾患であり、その重要性と発生率の高さから、成功する効率的な治療法の研究が集中しています。世界では、2017年の時点で2億人以上が末梢血管障害を患っています。同じ情報源によれば、これらの疾患の有病率は年齢とともに増加し、80歳以上の年齢層では20%以上の有病率が見られるといいます。さらに、肝細胞がんや肝臓がんの有病率の増加は、塞栓療法治療に関連する高い成功率と低い術後合併症の発生率とともに、近い将来、塞栓療法装置の必要性を高めると思われます。女性で9番目、男性で5番目に多く罹患しているがんは肝臓がんです。2018年には世界で84万人以上が新たに診断されました。また、英国では過去10年間に腎臓がんの罹患率が42%増加しました。男性の罹患率は38%、女性の増加率は44%でした。

塞栓療法市場：主な考察

調査アナリストの分析によると、世界市場は予測期間 (2025-2032年) に約8.60%のCAGRで毎年成長すると予測されます。

製品別に見ると、塞栓剤は2024年に最大市場シェアを示すと予測されました。

最終用途別に見ると、2024年には病院とクリニックが主要セグメントでした。

処置別では、経カテーテル動脈塞栓術が2024年の主要セグメント

地域別では、北米が2024年に収益を生み出す主要市場です。

塞栓療法市場：セグメンテーション分析

世界の塞栓療法市場は、製品、用途、最終用途、処置、地域によって区分されます。

製品別では、市場は塞栓コイル (押し込み型コイル、取り付け型コイル)、取り付け型バルーン、塞栓剤 (マイクロスフェア、液体塞栓剤)、塞栓プラグシステム、サポートデバイス (マイクロカテーテル、ガイドワイヤー) に分別されます。2024年の塞栓療法市場は塞栓剤が支配的です。多くの場合、インターベンショナル・ラジオロジー治療における塞栓剤の使用量が増加しているため、この分野が市場を独占しています。さらに、このカテゴリーは、薬物溶出性マイクロスフェア、鈍い塞栓のための校正されたマイクロスフェア、原発性または二次性肝疾患のための放射性イットリウム-90マイクロスフェアのようなそのような薬剤の開発により、予測期間中に最も速い速度で成長すると予測されています。マイクロスフェアーは肝細胞がんの治療に頻繁に使用されるため、その使用の増加は直接的にその需要に寄与しています。米国がん協会は、毎年世界中で約85万人の肝臓がんの診断が行われていると報告しています。さらに、このカテゴリーを推進するもう一つの重要な要因は、多目的で生分解性のマイクロスフェアを作る継続的な研究です。化学療法薬と治療用放射性核種を組み合わせることで、これらの微小球は肝細胞がんの効率的な治療を提供することができます。

最終用途に基づき、市場は病院・診療所、外来手術センター (ASC)、その他に分けられます。2024年には、病院・診療所のカテゴリーが圧倒的な市場シェアを占めています。塞栓剤と塞栓療法機器の主要な最終消費者は、重症治療室、小規模診療所、大病院です。これらの場所では、血管、神経、泌尿器科的介入のような低侵襲外科的処置の使用の増加により、塞栓療法処置の数が増加しています。塞栓療法では、インターベンショナル・ラジオロジー部門のような、包括的な患者ケアを促進するインフラが確立された施設が好まれます。病院は外来手術センターよりも患者数が多いため、塞栓療法機器や塞栓剤のニーズが高いです。このカテゴリの拡大は、大規模医療プロバイダーの購買力の増大と、米国や他の主要な欧州市場における塞栓療法処置に対する償還の利用可能性によっても促進されています。

塞栓療法市場：地域別分析

2024年、北米が塞栓療法で最大の市場シェアを占めたのは、最新の塞栓療法技術を有する専門医センター、インターベンショナルラジオロジー部門、最先端の医療施設など、高度に発達した先進的な医療インフラがあるからです。特に米国では、医療費が世界最高水準にあります。最先端技術の導入が促進されるだけでなく、医療資源への多額の投資により、塞栓療法のような最新の医療処置が広く利用されるようになっています。北米の医療人材は高度な資格と経験を有しており、専門看護師やインターベンショナル・ラジオロジストも含まれています。塞栓療法の効果的な実施と発展は、熟練した人材の確保にかかっています。また、この地域は技術的進歩や医学研究の最前線でもあります。

アジア太平洋地域は市場のかなりの部分を占めると予想されています。アジア太平洋地域では、がん、末梢血管疾患、神経疾患などの慢性疾患が増加しています。これらの状況は塞栓術の完璧な候補であるため、塞栓術のツールや処置に対するこの地域のニーズは高まっています。アジア太平洋地域では、政府や民間医療プロバイダーが最先端の医療技術や医療インフラへの投資を増やしています。世界で新たに発生するがん患者の50%はアジア太平洋地域で発生しており、2030年までにアジアでのがん関連死亡者数は36%増加すると予測されています。2024年には、子宮頸がんによる死亡者数の58%、乳がんによる診断者数の45%がアジアで発生すると世界経済フォーラムは予測しています。したがって、上記の要素がこの地域の主導的地位を維持すると予想されます。

塞栓療法市場：競合情勢

2024年6月ボストン・サイエンティフィックは、シリコンバレーを拠点とする医療機器会社Silk Road Medical Inc.の買収計画を発表。後者は、経頸動脈血行再建術と呼ばれる低侵襲治療により、頸動脈疾患患者の脳卒中回避を支援する製品を提供しています。

2024年2月フランスの大手医療画像AI専門企業であるAI社は、同社のCEマーク取得済みCINA-iPEソリューションをBlackford AI Platformに統合する戦略的提携を発表しました。この提携により、医療専門家は、標準的なCTスキャン中の偶発的な肺塞栓症をより正確に検出するための最先端のリソースを得ることができます。

2023年9月スウェーデンのCDMOで分解性デンプン微小球のベンダーであるマグレ・グループとサーテックス・メディカルは、独占的世界販売契約を発表しました。サーテックス・メディカルは提携の一環として、マグレグループのEmboCept S DSM 50μm化学塞栓療法製品を新規および既存市場で独占的に販売します。

目次

第1章 塞栓療法市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 塞栓療法の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 塞栓療法市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 塞栓療法市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 塞栓療法の市場情勢

  • 塞栓療法の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 塞栓療法市場：製品別

  • 概要
    • セグメント別シェア分析：製品別
    • 塞栓コイル
      • 押し込み型コイル
      • 取り付け型コイル
    • 取り付け型バルーン
    • 塞栓剤
      • マイクロスフィア
      • 液体塞栓剤
    • 塞栓プラグシステム
    • サポートデバイス
      • マイクロカテーテル
      • ガイドワイヤー

第8章 塞栓療法市場：用途別

  • 概要
    • セグメント別シェア分析：用途別
    • 腫瘍学
      • 肺がん
      • 腎臓がん
      • 肝臓がん
      • 乳がん
      • その他のがん
    • 末梢血管疾患
    • 泌尿器科・腎臓科
      • 子宮筋腫
      • 前立腺肥大症
      • その他の泌尿器科・腎臓科向け用途
    • 神経学
      • 脳動静脈奇形
      • 脳動脈瘤
    • 消化管障害

第9章 塞栓療法市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院と診療所
    • 外来手術センター (ASC)
    • その他

第10章 塞栓療法市場：処置別

  • 概要
    • セグメント別シェア分析：処置別
    • 経カテーテル動脈塞栓術
    • 経動脈化学塞栓術
    • 経カテーテル動脈放射線塞栓術/選択的内部放射線療法

第11章 塞栓療法市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第12章 主要ベンダー分析：塞栓療法業界

  • 競合ダッシュボード
  • 企業プロファイル
    • Terumo Corporation
    • Merit Medical Systems, Inc.
    • Simbionix USA Corporation
    • Cook
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Meril Life Sciences Pvt. Ltd.
    • Medtronic
    • BTG International Limited
    • ABK Biomedical
    • Abbott
    • AngioDynamics
    • IMBIOTECHNOLOGIES LTD.
    • Debakey Medlife Private Limited
    • Heraeus Holding
    • Guerbet
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • BD
    • Others

第13章 AnalystViewの全方位的分析

目次
Product Code: ANV4488

REPORT HIGHLIGHT

Embolotherapy Market size was valued at US$ 4,115.2 Million in 2024, expanding at a CAGR of 8.60% from 2025 to 2032.

Embolotherapy is the practice of treating or halting uncontrollable bleeding by blocking arteries with a device (such as a balloon catheter). By using this method, bleeding is managed, and tumours are decreased. By limiting abnormal blood vessels, this endovascular technique aims to halt bleeding. Postpartum conditions, pelvic tract bleeding, and cervical uprooted pregnancy are the main conditions treated with embolotherapy. Lesions to the liver, spleen, and kidneys are among the vascular, non-operative, and iatrogenic solid organ damage that this treatment has demonstrated potential to treat. Embolotherapy is used to remove duodenal varices, revascularize tissues and organs before surgery, and treat enlarged uterine fibroids. Selecting an embolization agent with the required degree of vascular blockage persistence is therefore required. The need for embolotherapy will expand due to the growing prevalence of liver and hepatic cancers, as well as the top manufacturers' heightened focus on technological advancements. Additionally, increased infrastructure construction expenses and better research & development skills to promote healthcare technology will drive growth in the embolotherapy market. Growing patient demand for minimally invasive procedures and increased personal disposable income are other factors driving market expansion.

Embolotherapy Market- Market Dynamics

Increase in target procedures due to the expanding target patient pool

The market for embolotherapy devices has grown steadily over the past ten years as a result of an increase in target procedures due to the expanding target patient pool. CVD is a major target illness, and because of its significance and high incidence, research on successful and efficient treatments has focused on it. Globally, more than 200 million people had peripheral vascular disorders as of 2017. The same source claims that the prevalence of these illnesses increases with age, with a prevalence rate of more than 20% seen in the over-80 age range. Moreover, The increasing prevalence of hepatocellular and liver cancers, along with the high success rate and low rate of post-operative complications linked to embolotherapy treatments, will increase the need for embolotherapy devices in the near future. The ninth most prevalent cancer in women and the fifth most common in men is liver cancer. More than 840,000 new cases were diagnosed worldwide in 2018. In addition, the UK had a 42% increase in kidney cancer incidence rates during the previous ten years. There was a 38% incidence rate in males and a 44% increase rate in females.

Embolotherapy Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 8.60% over the forecast period (2025-2032)

Based on product segmentation, the embolic agents were predicted to show maximum market share in the year 2024

Based on end use segmentation, hospitals and clinics were the leading segment in 2024

Based on procedure segmentation, Transcatheter Arterial Embolization was the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Embolotherapy Market- Segmentation Analysis:

The Global Embolotherapy Market is segmented on the basis of Product, Application, End Use, Procedure, and Region.

On the basis of product, the market is segregated into Embolization Coil (Pushable Coils, Detachable Coils), Detachable Balloons, Embolic Agents (Microspheres, Liquid Embolic Agents), Embolic Plug Systems, and Support Devices (Microcatheters, Guidewires). The market for embolotherapy is dominated by embolic agents in 2024. For the most part, this segment dominates the market because of the growing usage of embolic agents in several interventional radiological treatments. Additionally, the category is anticipated to grow at the fastest rate during the forecast period due to the developments in such agents, such as drug-eluting microspheres, calibrated microspheres for bland embolization, and radioactive yttrium-90 microspheres for primary or secondary liver diseases. Since microspheres are frequently employed to treat HCC, their increasing use directly contributes to the demand for them. The American Cancer Society reports that about 850,000 liver cancer diagnoses are made worldwide each year. Moreover, another important factor propelling this category is the continuous study of creating multipurpose and biodegradable microspheres. By combining chemotherapeutic drugs with therapeutic radionuclides, these microspheres can provide an efficient treatment for HCC.

Based on end use, the market is divided into Hospitals and Clinics, Ambulatory Surgical Centers (ASCs), and Others. In 2024, the hospitals and clinics category held a dominant market share. The primary end consumers of embolic agents and embolotherapy equipment are critical care units, minor clinics, and large hospitals. At these locations, the number of embolotherapy procedures is being driven by the growing use of minimally invasive surgical procedures, such as vascular, neurological, and urological interventions. For embolization operations, facilities with established infrastructure that facilitates all-encompassing patient care-such as interventional radiology departments-are favoured. There is a greater need for embolotherapy equipment and embolic agents in hospitals because they have more patients than ambulatory surgery centres. The expansion of this category is also fueled by the larger healthcare providers' growing purchasing power and the availability of reimbursement for embolotherapy procedures in the United States and other significant European markets.

Embolotherapy Market- Geographical Insights

In 2024, North America held the largest market share for embolotherapy because of its highly developed and advanced healthcare infrastructure, which includes specialist centres with the newest embolotherapy technology, interventional radiology departments, and state-of-the-art medical facilities. Particularly in the United States, healthcare spending is among the highest in the world. In addition to facilitating the adoption of cutting-edge technologies, the substantial investment in healthcare resources makes modern medical procedures, such as embolotherapy, widely accessible. The healthcare workforce in North America is highly qualified and experienced and includes specialized nursing personnel and interventional radiologists. The effective implementation and growth of embolotherapy treatments depend on the availability of skilled personnel. The area is also at the forefront of technical advancement and medical research.

The Asia-Pacific region is anticipated to account for a sizeable portion of the market. In Asia-Pacific nations, chronic illnesses like cancer, peripheral vascular disease, and neurological disorders are on the rise. The region's need for embolization tools and procedures is rising as a result of these situations being perfect candidates for embolization operations. In Asia Pacific, governments and private healthcare providers are investing more in state-of-the-art medical technology and healthcare infrastructure. 50% of all new cancer cases worldwide occur in Asia Pacific, and by 2030, the number of cancer-related fatalities in Asia is predicted to rise by 36%. In 2024, the World Economic Forum anticipated that 58% of cervical cancer fatalities and 45% of all breast cancer diagnoses globally occur in Asia. Therefore, it is anticipated that the elements above will maintain the region's leading position.

Embolotherapy Market- Competitive Landscape:

Key players in the embolotherapy market include Terumo Corporation, Merit Medical Systems, Inc., Simbionix USA Corporation, Cook, Boston Scientific Corporation, Penumbra, Inc., Meril Life Sciences Pvt. Ltd., Medtronic, and others. The market's companies have been concentrating on innovations. Offering more effective solutions in response to changing end-user needs is a major focus. The market for embolotherapy is thought to be fairly fragmented because of the large number of players. In addition, industry participants have made partnerships a crucial tactic in their efforts to broaden both their product offerings and their geographical presence. For instance, in December 2023, the innovative AZUR HydroPack Peripheral Coil System from Terumo Medical Corporation was introduced in the US. A platinum and hydrogel coil with a flexible, universal shape, the AZUR HydroPack Coil System is made to locate and fill space inside the vessel.

Recent Development

June 2024: Boston Scientific Corporation announced plans to buy Silk Road Medical Inc., a medical device firm based in Silicon Valley. Through a minimally invasive treatment called trans carotid artery revascularization, the latter provides products to help patients with carotid artery disease avoid strokes.

February 2024: Leading French medical imaging AI specialist AI announced a strategic partnership to integrate its CE-marked CINA-iPE solution into the Blackford AI Platform. This collaboration gives medical professionals cutting-edge resources to detect incidental pulmonary embolisms during standard CT scans more accurately.

September 2023: Magle Group, a Swedish CDMO and vendor of degradable starch microspheres, and Sirtex Medical announced an exclusive global distribution deal. Sirtex Medical exclusively distributes the EmboCept S DSM 50 μm chemoembolization product from Magle Group in both new and existing markets as part of the collaboration.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL EMBOLOTHERAPY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Terumo Corporation
  • Merit Medical Systems, Inc.
  • Simbionix USA Corporation
  • Cook
  • Boston Scientific Corporation
  • Penumbra, Inc.
  • Meril Life Sciences Pvt. Ltd.
  • Medtronic
  • BTG International Limited
  • ABK Biomedical
  • Abbott
  • AngioDynamics
  • IMBIOTECHNOLOGIES LTD.
  • Debakey Medlife Private Limited
  • Heraeus Holding
  • Guerbet
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • BD
  • Others

GLOBAL EMBOLOTHERAPY MARKET, BY PRODUCT- MARKET ANALYSIS, 2019 - 2032

  • Embolization Coil
  • Pushable Coils
  • Detachable Coils
  • Detachable Balloons
  • Embolic Agents
  • Microspheres
  • Liquid Embolic Agents
  • Embolic Plug Systems
  • Support Devices
  • Microcatheters
  • Guidewires

GLOBAL EMBOLOTHERAPY MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Lung Cancer
  • Kidney Cancer
  • Liver Cancer
  • Breast Cancer
  • Other Cancers
  • Peripheral Vascular Diseases
  • Urology and Nephrology
  • Uterine Fibroids
  • Benign Prostatic Hyperplasia
  • Other Urology and Nephrology Applications
  • Neurology
  • Cerebral Arteriovenous Malformations
  • Brain Aneurysm
  • GIT Disorders

GLOBAL EMBOLOTHERAPY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

GLOBAL EMBOLOTHERAPY MARKET, BY PROCEDURE- MARKET ANALYSIS, 2019 - 2032

  • Transcatheter Arterial Embolization
  • Transarterial Chemoembolization
  • Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

GLOBAL EMBOLOTHERAPY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Embolotherapy Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Embolotherapy Market Snippet by Product
    • 2.1.2. Embolotherapy Market Snippet by Application
    • 2.1.3. Embolotherapy Market Snippet by End Use
    • 2.1.4. Embolotherapy Market Snippet by Procedure
    • 2.1.5. Embolotherapy Market Snippet by Country
    • 2.1.6. Embolotherapy Market Snippet by Region
  • 2.2. Competitive Insights

3. Embolotherapy Key Market Trends

  • 3.1. Embolotherapy Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Embolotherapy Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Embolotherapy Market Opportunities
  • 3.4. Embolotherapy Market Future Trends

4. Embolotherapy Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Embolotherapy Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Embolotherapy Market Landscape

  • 6.1. Embolotherapy Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Embolotherapy Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Embolization Coil
      • 7.1.2.1. Pushable Coils
      • 7.1.2.2. Detachable Coils
    • 7.1.3. Detachable Balloons
    • 7.1.4. Embolic Agents
      • 7.1.4.1. Microspheres
      • 7.1.4.2. Liquid Embolic Agents
    • 7.1.5. Embolic Plug Systems
    • 7.1.6. Support Devices
      • 7.1.6.1. Microcatheters
      • 7.1.6.2. Guidewires

8. Embolotherapy Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Oncology
      • 8.1.2.1. Lung Cancer
      • 8.1.2.2. Kidney Cancer
      • 8.1.2.3. Liver Cancer
      • 8.1.2.4. Breast Cancer
      • 8.1.2.5. Other Cancers
    • 8.1.3. Peripheral Vascular Diseases
    • 8.1.4. Urology and Nephrology
      • 8.1.4.1. Uterine Fibroids
      • 8.1.4.2. Benign Prostatic Hyperplasia
      • 8.1.4.3. Other Urology and Nephrology Applications
    • 8.1.5. Neurology
      • 8.1.5.1. Cerebral Arteriovenous Malformations
      • 8.1.5.2. Brain Aneurysm
    • 8.1.6. GIT Disorders

9. Embolotherapy Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals and Clinics
    • 9.1.3. Ambulatory Surgical Centers (ASCs)
    • 9.1.4. Others

10. Embolotherapy Market - By Procedure

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Procedure, 2024 & 2032 (%)
    • 10.1.2. Transcatheter Arterial Embolization
    • 10.1.3. Transarterial Chemoembolization
    • 10.1.4. Transcatheter Arterial Radioembolization/Selective Internal Radiation Therapy

11. Embolotherapy Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Embolotherapy Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Embolotherapy Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.9. France
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.9.6. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.10. Italy
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.10.6. Italy Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.11. Spain
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.12. United Kingdom
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.12.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.12.6. United Kingdom Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.13. Russia
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.13.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.13.5. Russia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.14. Netherlands
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.14.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Netherlands Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.15. Sweden
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.15.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Sweden Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Embolotherapy Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.10. South Korea
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.10.6. South Korea Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.11. Japan
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.11.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.11.6. Japan Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Embolotherapy Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Embolotherapy Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Procedure, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Embolotherapy Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Terumo Corporation
    • 12.2.2. Merit Medical Systems, Inc.
    • 12.2.3. Simbionix USA Corporation
    • 12.2.4. Cook
    • 12.2.5. Boston Scientific Corporation
    • 12.2.6. Penumbra, Inc.
    • 12.2.7. Meril Life Sciences Pvt. Ltd.
    • 12.2.8. Medtronic
    • 12.2.9. BTG International Limited
    • 12.2.10. ABK Biomedical
    • 12.2.11. Abbott
    • 12.2.12. AngioDynamics
    • 12.2.13. IMBIOTECHNOLOGIES LTD.
    • 12.2.14. Debakey Medlife Private Limited
    • 12.2.15. Heraeus Holding
    • 12.2.16. Guerbet
    • 12.2.17. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 12.2.18. BD
    • 12.2.19. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us